Drug intelligence / Profile preview

uncaria rhynchophylla extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intranasal
01

Overview

**Uncaria rhynchophylla extract** is a botanical preparation derived from the hooks and stems of Uncaria rhynchophylla, a traditional Chinese medicinal plant known as "Gouteng". The primary active components are **indole alkaloids** (notably rhynchophylline, isorhynchophylline, corynoxine, and angustoline), with additional bioactive constituents including flavonoids and triterpenes. The extract has demonstrated a range of pharmacological activities: - **Neuroprotective effects:** Extensively studied for its protective actions in neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Mechanisms include inhibition of amyloid-beta and tau aggregation, activation of mitophagy (via UCHL1), modulation of neurotransmitter systems (notably the serotonergic pathway), and anti-inflammatory properties[2][3][4][5]. - **Vasodilatory/Antihypertensive effects:** Shows vasodilation mediated through the nitric oxide–soluble guanylyl cyclase–cyclic GMP (NO/sGC/cGMP) signaling, prostacyclin (PGI₂), M₃ and β₂ receptors, voltage-gated calcium channels, IP₃-induced intracellular Ca²⁺ release, and potassium channels (except KCa type)[1]. - **Other effects:** Traditional indications include treatment of dizziness, headaches, epilepsy, hypertension, stroke, anxiety, and convulsions. Modern pharmacological investigations also suggest antioxidant and anti-HIV activity[3][5][8]. Typical routes of administration are oral, but intranasal delivery has been studied for targeted brain effects[5]. The extract is mostly considered a herbal supplement rather than an approved pharmaceutical drug in any major regulatory jurisdiction.

Other names
uncaria rhynchophylla ethanolic extractUncariae Ramulus cum UncisGoutengUR extractURA
02

Targets

PXR (Pregnane X receptor)Amyloid-beta aggregate (N-terminal epitope)NOS2 (Nitric Oxide Synthase 2)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on uncaria rhynchophylla extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on uncaria rhynchophylla extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call